HealthCor Catalio Acquisition Corp.
Status: Deal Closed
U=S
| IPO Proceeds, $M | $207.00M |
|---|---|
| IPO Date | Jan 27, 2021 |
| CEO | Art Cohen |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Healthcare, including the biotechnology, pharmaceuticals, services, and medical technology sub-sectors |
| IPO Geography | Global |
| Target Company | Hyperfine and Liminal Sciences |
| Deal Announced | Jul 8, 2021 |
| Deal Size, $M | $581.30M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Dec 21, 2021 |
| Amendment Vote | TBD |
| Closing Date | Dec 22, 2021 |
Formerly HCAQ
HYPR
| Price | $0.99 |
|---|---|
| Last closing price | $1.00 |
| H/L, 52-week | $0.68 / $3.28 |
| Volume, today | 24,126 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on HealthCor Catalio Acquisition Corp.:
- Structure and cap table
- 9 directors & officers
- 22 filings and events
- 1 underwriters
- 7 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Art Cohen | 59 | CEO and Director |
| Christine Clarke | 42 | CFO |
| George Petrocheilos | 29 | President |
| Joseph Healey | 54 | Chairman |
| Avi Horev | 46 | Director |
| Dr. Kenan Turnacioglu | 50 | Director |
| Michael Weinstein | 50 | Director |
| Taylor Harris | 44 | Director |
| Dr. Christopher Wolfgang | 54 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Jefferies | BR | 18,000,000 | units |
| 18,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.